3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
2
Tumor-Agnostic
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Stroke
1
Neurologic Manifestations
1
Neoplasms
1
Margins of Excision
1
Glioblastoma
1
Communication
1
Caregiver Burden
1
Brain Neoplasms
1
Brain Injuries, Traumatic
1
Brain Injuries
1
Interventions
Temozolomide
31
Magnetic Resonance Spectroscopy
31
Specimen Handling
18
Radiation
13
Radiotherapy
12
Biopsy
11
Bevacizumab
11
Nivolumab
9
X-Rays
7
Radiosurgery
7
Nuclear Medicine Department, Hospital
7
Carboplatin
7
Lomustine
6
Cyclophosphamide
6
Vincristine
5
Phantoms, Imaging
5
Cisplatin
5
ulixertinib
4
trametinib
4
pembrolizumab
4
erdafitinib
4
binimetinib
4
abemaciclib
4
Irinotecan
4
Ipilimumab
4
Immunoglobulin G
4
Etoposide
4
Disulfides
4
Aminolevulinic Acid
4
AZD 6244
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Palliative Care
×
CNS
×
30 days
×
Clear all
NCT07590726
2026-05-19
PIRe
Rigshospitalet, Denmark
Phase NA
Not yet recruiting
160 enrolled